Advisor Group Holdings Inc. Grows Position in The Cooper Companies, Inc. (NYSE:COO)

Posted by Defense World Staff on Jun 1st, 2023

Advisor Group Holdings Inc. grew its position in The Cooper Companies, Inc. (NYSE:COO – Get Rating) by 5.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,338 shares of the medical device company’s stock after acquiring an additional 825 shares during the quarter. Advisor Group Holdings Inc.’s holdings in Cooper Companies were worth $5,734,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Greenwood Capital Associates LLC bought a new position in Cooper Companies during the 4th quarter worth about $25,000. Belpointe Asset Management LLC acquired a new stake in shares of Cooper Companies during the 4th quarter worth approximately $30,000. Denali Advisors LLC acquired a new stake in shares of Cooper Companies during the 4th quarter worth approximately $33,000. CI Investments Inc. grew its stake in shares of Cooper Companies by 60.7% during the 3rd quarter. CI Investments Inc. now owns 135 shares of the medical device company’s stock worth $36,000 after purchasing an additional 51 shares during the period. Finally, Standard Family Office LLC acquired a new stake in Cooper Companies in the 3rd quarter valued at $37,000. Hedge funds and other institutional investors own 96.78% of the company’s stock.

Cooper Companies Stock Performance

Shares of COO opened at $371.63 on Thursday. The company has a quick ratio of 1.00, a current ratio of 1.72 and a debt-to-equity ratio of 0.36. The Cooper Companies, Inc. has a 52-week low of $244.21 and a 52-week high of $395.20. The stock has a 50 day moving average price of $376.69 and a 200 day moving average price of $348.46. The company has a market capitalization of $18.38 billion, a price-to-earnings ratio of 49.22, a price-to-earnings-growth ratio of 2.63 and a beta of 0.91.

Cooper Companies (NYSE:COO – Get Rating) last issued its quarterly earnings data on Thursday, March 2nd. The medical device company reported $2.90 earnings per share for the quarter, beating analysts’ consensus estimates of $2.66 by $0.24. Cooper Companies had a return on equity of 8.39% and a net margin of 11.10%. The company had revenue of $858.50 million during the quarter, compared to analysts’ expectations of $834.90 million. During the same quarter in the previous year, the business earned $3.24 earnings per share. The firm’s revenue for the quarter was up 9.1% on a year-over-year basis. Research analysts predict that The Cooper Companies, Inc. will post 12.73 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on COO shares. Wells Fargo & Company lifted their target price on shares of Cooper Companies from $355.00 to $430.00 in a research note on Monday, May 15th. Morgan Stanley started coverage on shares of Cooper Companies in a research note on Tuesday. They set an “equal weight” rating and a $410.00 target price on the stock. Piper Sandler lifted their target price on shares of Cooper Companies from $375.00 to $430.00 in a research note on Wednesday, May 24th. StockNews.com initiated coverage on Cooper Companies in a report on Thursday, May 18th. They set a “hold” rating on the stock. Finally, Stifel Nicolaus boosted their price objective on shares of Cooper Companies from $380.00 to $420.00 in a report on Tuesday, May 16th. Three equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $399.82.

Insider Transactions at Cooper Companies

In other Cooper Companies news, Director Robert S. Weiss sold 37,510 shares of the stock in a transaction on Tuesday, March 7th. The stock was sold at an average price of $337.72, for a total value of $12,667,877.20. Following the completion of the transaction, the director now owns 70,000 shares in the company, valued at $23,640,400. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Cooper Companies news, COO Gerard H. Warner III sold 1,216 shares of the company’s stock in a transaction on Thursday, March 9th. The stock was sold at an average price of $340.53, for a total value of $414,084.48. Following the sale, the chief operating officer now owns 1,290 shares of the company’s stock, valued at $439,283.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert S. Weiss sold 37,510 shares of the company’s stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $337.72, for a total value of $12,667,877.20. Following the completion of the sale, the director now directly owns 70,000 shares in the company, valued at approximately $23,640,400. The disclosure for this sale can be found here. Insiders sold 39,726 shares of company stock worth $13,451,962 over the last 90 days. 2.00% of the stock is currently owned by insiders.

About Cooper Companies

(Get Rating)

The Cooper Cos, Inc operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues.

Institutional Ownership by Quarter for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.